Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash and Bank

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash and Bank ₹1,659 Cr₹1,160 Cr₹1,412 Cr₹1,139 Cr₹1,111 Cr

What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS is ₹1,659 Cr based on Mar2024 Consolidated results.
Year Cash and Bank
Mar2024₹1,659 Cr
Mar2023₹1,160 Cr
Mar2022₹1,412 Cr
Mar2021₹1,139 Cr
Mar2020₹1,111 Cr

How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?

Years Cash and Bank % Change
Mar2024 ₹1,659 Cr
43.02
Mar2023 ₹1,160 Cr
-17.80
Mar2022 ₹1,412 Cr
23.91
Mar2021 ₹1,139 Cr
2.51
Mar2020 ₹1,111 Cr -

Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,438.2 Cr -2% -3.7% 60.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,557.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹156,994.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,494.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹109,297.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,035.0 Cr 2% 1.5% 38% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2%

-3.7%

60.5%

SENSEX

-1%

-5%

5.6%


You may also like the below Video Courses